_version_ 1784780023293542400
author Ortiz De Landazuri, I.
Oliver-Caldés, A.
Español-Rego, M.
Contreras, M. T.
Zabaleta, A.
Agulló, C.
Puig, N.
Cabañas, V.
González-Calle, V.
Jiménez, R.
Inogés, S.
Rodríguez-Otero, P.
Martin-Antonio, B.
Reguera, J. L.
López-Diaz de Cerio, A.
Benítez-Ribas, D.
Rodríguez-Lobato, L. G.
González, E. A.
Rosiñol, L.
Yagüe, J.
Moraleda, J. M.
Urbano-Ispizua, Á.
Mateos, M. V.
Juan, M.
Paiva, B.
Pascal, M.
Fernández de Larrea, C.
author_facet Ortiz De Landazuri, I.
Oliver-Caldés, A.
Español-Rego, M.
Contreras, M. T.
Zabaleta, A.
Agulló, C.
Puig, N.
Cabañas, V.
González-Calle, V.
Jiménez, R.
Inogés, S.
Rodríguez-Otero, P.
Martin-Antonio, B.
Reguera, J. L.
López-Diaz de Cerio, A.
Benítez-Ribas, D.
Rodríguez-Lobato, L. G.
González, E. A.
Rosiñol, L.
Yagüe, J.
Moraleda, J. M.
Urbano-Ispizua, Á.
Mateos, M. V.
Juan, M.
Paiva, B.
Pascal, M.
Fernández de Larrea, C.
author_sort Ortiz De Landazuri, I.
collection PubMed
description
format Online
Article
Text
id pubmed-9431324
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313242022-08-31 P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY Ortiz De Landazuri, I. Oliver-Caldés, A. Español-Rego, M. Contreras, M. T. Zabaleta, A. Agulló, C. Puig, N. Cabañas, V. González-Calle, V. Jiménez, R. Inogés, S. Rodríguez-Otero, P. Martin-Antonio, B. Reguera, J. L. López-Diaz de Cerio, A. Benítez-Ribas, D. Rodríguez-Lobato, L. G. González, E. A. Rosiñol, L. Yagüe, J. Moraleda, J. M. Urbano-Ispizua, Á. Mateos, M. V. Juan, M. Paiva, B. Pascal, M. Fernández de Larrea, C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431324/ http://dx.doi.org/10.1097/01.HS9.0000846328.56229.e7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Ortiz De Landazuri, I.
Oliver-Caldés, A.
Español-Rego, M.
Contreras, M. T.
Zabaleta, A.
Agulló, C.
Puig, N.
Cabañas, V.
González-Calle, V.
Jiménez, R.
Inogés, S.
Rodríguez-Otero, P.
Martin-Antonio, B.
Reguera, J. L.
López-Diaz de Cerio, A.
Benítez-Ribas, D.
Rodríguez-Lobato, L. G.
González, E. A.
Rosiñol, L.
Yagüe, J.
Moraleda, J. M.
Urbano-Ispizua, Á.
Mateos, M. V.
Juan, M.
Paiva, B.
Pascal, M.
Fernández de Larrea, C.
P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY
title P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY
title_full P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY
title_fullStr P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY
title_full_unstemmed P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY
title_short P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY
title_sort p862: serum mass spectrometry to analyze disease response in patients with relapsed/refractory multiple myeloma receiving ari0002h, an academic bcma-directed car t-cell therapy
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431324/
http://dx.doi.org/10.1097/01.HS9.0000846328.56229.e7
work_keys_str_mv AT ortizdelandazurii p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT olivercaldesa p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT espanolregom p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT contrerasmt p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT zabaletaa p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT agulloc p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT puign p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT cabanasv p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT gonzalezcallev p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT jimenezr p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT inogess p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT rodriguezoterop p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT martinantoniob p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT reguerajl p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT lopezdiazdecerioa p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT benitezribasd p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT rodriguezlobatolg p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT gonzalezea p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT rosinoll p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT yaguej p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT moraledajm p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT urbanoispizuaa p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT mateosmv p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT juanm p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT paivab p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT pascalm p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy
AT fernandezdelarreac p862serummassspectrometrytoanalyzediseaseresponseinpatientswithrelapsedrefractorymultiplemyelomareceivingari0002hanacademicbcmadirectedcartcelltherapy